Muscle strength · patients with the treatment of amyotrophic lateral sclerosis or motor neuron disease
1 finding from 1 review
Changes to FSS at 12 months · patients with the treatment of amyotrophic lateral sclerosis or motor neuron disease
1 finding from 1 review
Withdrawals due to adverse events · patients with the treatment of amyotrophic lateral sclerosis or motor neuron disease
1 finding from 1 review
Intervention not reported
rhIGF‐I, 0.1 mg/kg/day ‐ survival at12 months · patients with amyotrophic lateral sclerosis/motor neuron disease
1 finding from 1 review
Intervention not reported
rhIGF‐I, 0.1 mg/kg/day ‐ change in AALSRS at 9 months · patients with amyotrophic lateral sclerosis/motor neuron disease
1 finding from 1 review
Intervention not reported
rhIGF‐I, 0.1 mg/kg/day ‐ change in SIP after 9 months · patients with amyotrophic lateral sclerosis/motor neuron disease
1 finding from 1 review
no estimate extracted
156 participants
Low
Intervention not reported
rhIGF‐I, all doses ‐ injection site pain · patients with amyotrophic lateral sclerosis/motor neuron disease
1 finding from 1 review
Intervention not reported
rhIGF‐I, all doses ‐ injection site inflammation/reaction · patients with amyotrophic lateral sclerosis/motor neuron disease
1 finding from 1 review
Intervention not reported
Tracheostomy‐free survival · patients with amyotrophic lateral sclerosis
1 finding from 1 review
Intervention not reported
ALSFRS‐R slope Change in ALSFRS‐R / month · patients with amyotrophic lateral sclerosis
1 finding from 1 review
Intervention not reported
FVC Slope Change in FVC / month · patients with amyotrophic lateral sclerosis
1 finding from 1 review
Intervention not reported
Pain ‐ not measured · patients with chronic (>12 months) lateral elbow pain
The review found no eligible studies for this question.
1 finding from 1 review
Intervention not reported
Adverse events ‐ not measured · patients with chronic (mean 23 months) lateral elbow pain
The review found no eligible studies for this question.
1 finding from 1 review
Intervention not reported
Pain ‐ not reported · patients with chronic (>6 months) lateral elbow pain
The review found no eligible studies for this question.
1 finding from 1 review
Intervention not reported
Disabilty ‐ not measured · patients with chronic (>6 months) lateral elbow pain
The review found no eligible studies for this question.
1 finding from 1 review
Intervention not reported
Adverse events ‐ not measured · patients with chronic (>6 months) lateral elbow pain
The review found no eligible studies for this question.
1 finding from 1 review
Intervention not reported
Disability DASH scale. Scale from: 0 to 100. ( · patients with chronic (>12 months) lateral elbow pain
1 finding from 1 review
Intervention not reported
Adverse events ‐ not measured · patients with chronic (>12 months) lateral elbow pain
The review found no eligible studies for this question.
1 finding from 1 review
Intervention not reported
Pain‐ short term VAS scale. Scale from: 0 to 10. ( · patients with lateral elbow pain
1 finding from 1 review
Intervention not reported
Pain‐ long term VAS. Scale from: 0 to 10. ( · patients with lateral elbow pain
1 finding from 1 review